Duration of effectiveness of botulinum toxin type B in the treatment of cervical dystonia.
D001905:Botulinum Toxins / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D009460:Neurologic Examination; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D011930:Reaction Time / Q000187:drug effects; D012720:Severity of Illness Index; D013997:Time Factors; D014103:Torticollis / Q000188:drug therapy*; D016896:Treatment Outcome
D009465:Neuromuscular Agents; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A